Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nihon Shokuhin Kako Co., Ltd. is a leading Japanese corn refiner that produces a wide range of starch-based products for the food, pharmaceutical, and industrial sectors. The company is particularly noted for its expertise in carbohydrate chemistry and enzymatic processing, which it uses to manufacture high-purity cyclodextrins. These cyclodextrins serve as critical pharmaceutical excipients, enhancing the bioavailability and stability of various drug formulations. As a member of the Mitsubishi Corporation Group, the company maintains a robust supply chain and advanced manufacturing facilities, including its primary plant in Fuji. Their product portfolio also includes high-fructose corn syrup, glucose, and specialty modified starches. Nihon Shokuhin Kako continues to innovate in the field of functional ingredients, supporting both clinical nutrition and pharmaceutical development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nihon Shokuhin Kako.